"There’s been a real shortage of these products, particularly since they share production with, for example, the diabetes and ...
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
South Africa's Competition Commission investigates Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market.
The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...
South Africa's competition watchdog is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
The development of AI-powered smart insulin pens with machine learning algorithms is transforming diabetes management. Features such as automated dose reminders, real-time glucose monitoring ...
Travelling can be thrilling and overwhelming, especially when you’re managing a chronic condition like diabetes. The idea of ...
8d
Inquirer on MSNUS approves 1st fast-acting insulin biosimilar for diabetesThe US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood sugar levels. It calls ...
9d
Daily Maverick on MSNSA competition watchdog probes Novo Nordisk and Sanofi over insulinSouth Africa's Competition Commission is investigating drugmakers Novo Nordisk and Sanofi over possible anti-competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results